News
Novavax begins phase III coronavirus vaccine trial in the UK
Novavax has initiated a phase III study of its COVID-19 vaccine candidate in the UK, which will aim to enrol up to 10,000 volunteers.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Novavax has initiated a phase III study of its COVID-19 vaccine candidate in the UK, which will aim to enrol up to 10,000 volunteers.